Cara Therapeutics, Inc. (CARA)

Cara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	15	40	577	651	754	752
Market Cap Growth	-81.22%	-92.99%	-11.37%	-13.64%	0.26%	46.64%
Enterprise Value	-9	-18	433	488	578	601
PE Ratio	-	-0.34	-6.75	-7.36	89.65	-7.07
PS Ratio	0.90	1.93	13.78	28.28	5.58	37.82
PB Ratio	0.51	0.71	3.64	2.86	3.03	4.03
P/FCF Ratio	-0.55	-0.43	-7.33	-10.84	-129.19	-6.88
P/OCF Ratio	-0.57	-0.44	-7.33	-10.84	-137.41	-6.88
EV/Sales Ratio	1.50	-0.84	10.35	21.18	4.28	30.22
EV/EBITDA Ratio	-0.22	0.15	-5.17	-5.61	66.17	-5.65
EV/EBIT Ratio	-0.21	0.15	-5.07	-5.52	74.87	-5.61
EV/FCF Ratio	-0.28	0.19	-5.50	-8.12	-99.02	-5.50
Debt / Equity Ratio	1.52	0.76	0.01	0.02	0.02	0.02
Debt / EBITDA Ratio	-0.39	-0.37	-0.02	-0.04	0.60	-0.04
Debt / FCF Ratio	-0.50	-0.46	-0.02	-0.06	-0.90	-0.04
Quick Ratio	4.77	4.08	6.38	9.51	9.84	3.65
Current Ratio	5.38	4.54	7.20	9.84	10.55	3.86
Asset Turnover	0.14	0.16	0.20	0.10	0.69	0.10
Interest Coverage	-46.39	-195.21	-	-	-	-
Return on Equity (ROE)	-174.20%	-122.10%	-45.50%	-40.70%	5.00%	-69.40%
Return on Assets (ROA)	-105.30%	-89.60%	-40.40%	-37.50%	4.30%	-52.10%
Return on Capital (ROIC)	-164.19%	-121.19%	-54.47%	-38.53%	2.31%	-58.46%
Earnings Yield	-806.50%	-292.78%	-14.81%	-13.58%	1.12%	-14.15%
FCF Yield	-599.72%	-233.34%	-13.65%	-9.22%	-0.77%	-14.53%
Buyback Yield / Dilution	-1.33%	-0.92%	-5.79%	-5.85%	-12.29%	-18.88%
Total Shareholder Return	-1.33%	-0.92%	-5.79%	-5.85%	-12.29%	-18.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).